Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications
ABSTRACT Objective: To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. Methods: An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
|
Series: | Einstein (São Paulo) |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000300203&lng=en&tlng=en |
id |
doaj-875ef6a5c9c84153af3c04c20cbfb497 |
---|---|
record_format |
Article |
spelling |
doaj-875ef6a5c9c84153af3c04c20cbfb4972020-11-25T00:55:17ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)2317-638517310.31744/einstein_journal/2019ao4521S1679-45082019000300203Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medicationsThiago de Lima PessoaWashington Sales Clemente JuniorTatiana Xavier da CostaPriscilla Karilline do Vale BezerraRand Randall MartinsABSTRACT Objective: To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. Methods: An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensive care unit. Clinical data were collected and severe potential drug interactions were identified on pregnant inpatients. The drug interactions were classified by type, prevalence and exposure rate. A multivariate logistic regression model was used to identify the severe potential drug interactions and the related drugs (p<0.05). Results: A total of 95.1% of patients were exposed to, at least, one potential drug interaction; in that, 91.7% 33.9% were related to, respectively, moderate and severe potential drug interactions. The patients were exposed, on average, on 69.2% of days they were in the intensive care unit. The main drugs involved in more severe drug interactions were magnesium sulfate, metoclopramide, propranolol and diazepam. Conclusion: The severe potential drug interactions were observed in almost all patients of the study, and, approximately one third of those interactions were related to greater severity and resulted in exposure during long hospital stay. The higher number of prescribed drugs and its previous use of medications at home increase the occurrence of severe potential drug interactions.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000300203&lng=en&tlng=enInterações de medicamentosUnidade de terapia intensivaSaúde maternaTratamento farmacológicoGravidez |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Thiago de Lima Pessoa Washington Sales Clemente Junior Tatiana Xavier da Costa Priscilla Karilline do Vale Bezerra Rand Randall Martins |
spellingShingle |
Thiago de Lima Pessoa Washington Sales Clemente Junior Tatiana Xavier da Costa Priscilla Karilline do Vale Bezerra Rand Randall Martins Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications Einstein (São Paulo) Interações de medicamentos Unidade de terapia intensiva Saúde materna Tratamento farmacológico Gravidez |
author_facet |
Thiago de Lima Pessoa Washington Sales Clemente Junior Tatiana Xavier da Costa Priscilla Karilline do Vale Bezerra Rand Randall Martins |
author_sort |
Thiago de Lima Pessoa |
title |
Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications |
title_short |
Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications |
title_full |
Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications |
title_fullStr |
Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications |
title_full_unstemmed |
Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications |
title_sort |
drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications |
publisher |
Instituto Israelita de Ensino e Pesquisa Albert Einstein |
series |
Einstein (São Paulo) |
issn |
2317-6385 |
description |
ABSTRACT Objective: To characterize severe potential drug interactions in maternal intensive care, and to determine their frequency, risk factors and potential risk medications. Methods: An observational and longitudinal study conducted between December 2014 and December 2015 in a maternal intensive care unit. Clinical data were collected and severe potential drug interactions were identified on pregnant inpatients. The drug interactions were classified by type, prevalence and exposure rate. A multivariate logistic regression model was used to identify the severe potential drug interactions and the related drugs (p<0.05). Results: A total of 95.1% of patients were exposed to, at least, one potential drug interaction; in that, 91.7% 33.9% were related to, respectively, moderate and severe potential drug interactions. The patients were exposed, on average, on 69.2% of days they were in the intensive care unit. The main drugs involved in more severe drug interactions were magnesium sulfate, metoclopramide, propranolol and diazepam. Conclusion: The severe potential drug interactions were observed in almost all patients of the study, and, approximately one third of those interactions were related to greater severity and resulted in exposure during long hospital stay. The higher number of prescribed drugs and its previous use of medications at home increase the occurrence of severe potential drug interactions. |
topic |
Interações de medicamentos Unidade de terapia intensiva Saúde materna Tratamento farmacológico Gravidez |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000300203&lng=en&tlng=en |
work_keys_str_mv |
AT thiagodelimapessoa druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications AT washingtonsalesclementejunior druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications AT tatianaxavierdacosta druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications AT priscillakarillinedovalebezerra druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications AT randrandallmartins druginteractionsinmaternalintensivecareprevalenceriskfactorsandpotentialriskmedications |
_version_ |
1725230932120567808 |